Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brittany C Lipchick

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacological Research|February 2, 2016
Oxidative stress and proteasome inhibitors in multiple myelomaBrittany C Lipchick, Emily E Fink, Mikhail A Nikiforov
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2016
The Immortal SenescenceAnna Bianchi-Smiraglia, Brittany C Lipchick, Mikhail A Nikiforov
Blood Advances|April 6, 2021
The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myelomaBrittany C Lipchick, Adam Utley, Zhannan Han, et al.
Cell Reports|October 4, 2018
XBP1-KLF9 Axis Acts as a Molecular Rheostat to Control the Transition from Adaptive to Cytotoxic Unfolded Protein ResponseEmily E Fink, Sudha Moparthy, Archis Bagati, et al.
Nature Methods|September 5, 2017
Internally ratiometric fluorescent sensors for evaluation of intracellular GTP levels and distributionAnna Bianchi-Smiraglia, Mitra S Rana, Colleen E Foley, et al.
Cell Reports|September 21, 2017
Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1Archis Bagati, Anna Bianchi-Smiraglia, Sudha Moparthy, et al.
Oncogene|January 22, 2019
KLF9-dependent ROS regulate melanoma progression in stage-specific mannerArchis Bagati, Sudha Moparthy, Emily E Fink, et al.
The Journal of Clinical Investigation|September 11, 2018
Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myelomaAnna Bianchi-Smiraglia, Archis Bagati, Emily E Fink, et al.
Cell Death and Differentiation|February 22, 2018
FOXQ1 controls the induced differentiation of melanocytic cellsArchis Bagati, Anna Bianchi-Smiraglia, Sudha Moparthy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacological Research|February 2, 2016
Oxidative stress and proteasome inhibitors in multiple myelomaBrittany C Lipchick, Emily E Fink, Mikhail A Nikiforov
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2016
The Immortal SenescenceAnna Bianchi-Smiraglia, Brittany C Lipchick, Mikhail A Nikiforov
Blood Advances|April 6, 2021
The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myelomaBrittany C Lipchick, Adam Utley, Zhannan Han, et al.
Cell Reports|October 4, 2018
XBP1-KLF9 Axis Acts as a Molecular Rheostat to Control the Transition from Adaptive to Cytotoxic Unfolded Protein ResponseEmily E Fink, Sudha Moparthy, Archis Bagati, et al.
Nature Methods|September 5, 2017
Internally ratiometric fluorescent sensors for evaluation of intracellular GTP levels and distributionAnna Bianchi-Smiraglia, Mitra S Rana, Colleen E Foley, et al.
Cell Reports|September 21, 2017
Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1Archis Bagati, Anna Bianchi-Smiraglia, Sudha Moparthy, et al.
Oncogene|January 22, 2019
KLF9-dependent ROS regulate melanoma progression in stage-specific mannerArchis Bagati, Sudha Moparthy, Emily E Fink, et al.
The Journal of Clinical Investigation|September 11, 2018
Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myelomaAnna Bianchi-Smiraglia, Archis Bagati, Emily E Fink, et al.
Cell Death and Differentiation|February 22, 2018
FOXQ1 controls the induced differentiation of melanocytic cellsArchis Bagati, Anna Bianchi-Smiraglia, Sudha Moparthy, et al.
Pageof 1